Specialty pharmaceuticals are complex to manufacture and distribute, often difficult to administer, may require special patient monitoring and are a rapidly growing share of the costs to health plans. Payers are exploring ways to decrease the cost of these drugs; Comparative Effectiveness Research is one tool being discussed. Read more. (Source: NPC, Dec 2013).
You are here: / / Could CER Help Lower Costs Of Specialty Pharmaceuticals?